EANS 2022 Congress, Belgrade – Thank you

Posted on Posted in Uncategorized

Distinguished Official Representatives of the Republic of Serbia,
Distinguished EANS Office holders,
Distinguished EANS Staff,
Distinguished Aim Group representatives,
Distinguished Members of the Serbian Neurosurgical Society,
Distinguished Members of the Local Scientific Committee,
Distinguished Industry Partners,
Distinguished Suppliers, Supporters, and Friends,

I am writing to express my gratitude for your valuable contribution to the EANS Congress 2022 organization last month in Belgrade. I am confident you have all enjoyed it, and I am happy that we have received positive feedback from the EANS Board, participants, and Industry partners.
As you all know, the Congress was a great success, both scientifically and socially, and will remain in the EANS history as a legacy event.
We prepared this historical event with great care and dedication, and I appreciate the efforts of each of you. I couldn’t be more proud and grateful for everything we achieved.
Even three weeks after the Congress, the social networks are full of reactions from satisfied participants. I copied some of the impressions and news below.
I am looking forward to our next cooperation and to seeing you soon.
You are cordially invited to our 2022 annual meeting in December and the celebration of the centennial anniversary next year in October.
Always on the move, never standing still!
Of course, one for the road is waiting for all of us wherever and whenever!
All the best,
Prof. Dr. Lukas Rasulic
EANS 2022 Congress President
President of the Serbian Neurosurgical Society

EANS 2022 Social Media Presence
Day 1
Day 2
Day 3
Day 4
Day 5
EANS Monthly Digest
See you in Barcelona 2023
LinkedIn 1
LinkedIn 2
LinkedIn 3
LinkedIn 4
LinkedIn 5
LinkedIn 6
LinkedIn 7
LinkedIn 8
LinkedIn 9
LinkedIn 10
LinkedIn 11
LinkedIn 12
LinkedIn 13
LinkedIn 14
LinkedIn 15
LinkedIn 16
LinkedIn 17
LinkedIn 18
LinkedIn 19
LinkedIn 20
LinkedIn 21
LinkedIn 22
LinkedIn 23
LinkedIn 24
LinkedIn 25
LinkedIn 26
LinkedIn 27
LinkedIn 28
LinkedIn 29
LinkedIn 30
LinkedIn 31
LinkedIn 32
LinkedIn 33
LinkedIn 34
LinkedIn 35
LinkedIn 36
LinkedIn 37
LinkedIn 38
LinkedIn 39
News 1
News 2
News 3
News 4
News 5
News 6
News 7